Tech Company Financing Transactions

Tangen Bioscience Funding Round

On 12/31/2015, Tangen Bioscience secured $1 million in funding from Connecticut Innovations and private investors.

Transaction Overview

Company Name
Announced On
12/31/2015
Transaction Type
Venture Equity
Amount
$1,032,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
780 East Main St. 1
Branford, CT 06405
USA
Email Address
Not Recorded
Overview
Tangen Bioscience's instrument provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction (PCR) amplification, in a format that does not require laboratory resources or highly skilled operators.
Profile
Tangen Bioscience LinkedIn Company Profile
Social Media
Tangen Bioscience Company Twitter Account
Company News
Tangen Bioscience News
Facebook
Tangen Bioscience on Facebook
YouTube
Tangen Bioscience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rick Birkmeyer
  Rick Birkmeyer LinkedIn Profile  Rick Birkmeyer Twitter Account  Rick Birkmeyer News  Rick Birkmeyer on Facebook
Chief Scientific Officer
John Davidson
  John Davidson LinkedIn Profile  John Davidson Twitter Account  John Davidson News  John Davidson on Facebook
VP - Engineering
Bernard Puc
  Bernard Puc LinkedIn Profile  Bernard Puc Twitter Account  Bernard Puc News  Bernard Puc on Facebook
VP - Finance
Anne Cavanaugh
  Anne Cavanaugh LinkedIn Profile  Anne Cavanaugh Twitter Account  Anne Cavanaugh News  Anne Cavanaugh on Facebook
VP - Operations
Brian Chirico
  Brian Chirico LinkedIn Profile  Brian Chirico Twitter Account  Brian Chirico News  Brian Chirico on Facebook
VP - Regulatory Affairs
Keith Kardos
  Keith Kardos LinkedIn Profile  Keith Kardos Twitter Account  Keith Kardos News  Keith Kardos on Facebook
VP - Regulatory Affairs
Robert McNamee
  Robert McNamee LinkedIn Profile  Robert McNamee Twitter Account  Robert McNamee News  Robert McNamee on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2015: Kapteyn-Murnane Laboratories venture capital transaction
Next: 12/31/2015: Inprentus venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary